February 2022
Issue 1
Letter From the President
In the past two years, we had to tolerate much more uncertainty than usual. As clinical and translational researchers, we understand that there is always a degree of error in our scientific findings. However, juggling the degree of uncertainty caused by the COVID-19 pandemic in making decisions for our families, our workplaces and ourselves has been a daunting task. We continue immersed in this uncertainty as we prepare for Translational Science 2022.
We are excited to have a final scientific program that we are certain will meet the expectations of all our members. Our meeting will continue to have all the core activities such as Mock Study and Advocacy Training. This year we are highlighting the work of our special interest groups and have a special session where they will be able to present the state of the field of each group. Our program will follow topic tracks such as community engagement, diversity, equity and inclusion, workforce development and education, and valued approaches.
We have been continuously monitoring the COVID-19 mandates in Chicago to be able to provide a safe and productive environment for all our members. We will also livestream some of our sessions as we understand that some of our members will not be able to travel to Chicago. However, our in-person experience will certainly provide an opportunity to connect and interact that online venues have just not been able to substitute.
If you are still uncertain about traveling to Chicago for our annual meeting, we understand. Many of us are not sure if we want to go back to hectic travel schedules after these two years of online meetings. Our meeting will be a great starting point to discuss how we see collaborations and interactions changing with what we have learned with the pandemic.
Karen G. Martinez-Gonzalez, MD, MSc
ACTS President
Translational Science 2022: Early Bird Deadline Approaching
Translational Science: Transformational Translational Science: Opportunities for Success will return in person April 20-22, 2022 in Chicago, Illinois!
Whether you're looking for insights to kick start your next research project, resources to advance your career, or time to explore new opportunities for collaboration, we've got you covered.
Register by Monday, February 14 to take advantage of early bird pricing.
Journal of Clinical and Translational Science: The Official Journal of ACTS and CR Forum
Share innovative advances in the translational science area to the global research community through JCTS!
- Gold Open Access: fully compliant with Open Access Mandates
- Articles funded by the NIH will be manually sent to PubMed Central
- Articles appear with their final citation details as soon as they are published online
- Prestigious editorial board listing
- Global dissemination of your paper
- Metrics, Altmetrics and Kudos to monitor submissions
Want to receive alerts when new articles are published? Click the 'Add Alert' (🔔) icon here, then login or register for a Cambridge Core account to receive daily, weekly, or monthly updates.
PHRMA Funding Opportunity in Translational Medicine
The PhRMA Foundation’s 2022 Translational Medicine Award program offers postdoctoral fellowships and research starter grants to deserving researchers focused on developing solutions to complex clinical problems.
The goal of the program is to promote the development of an integrative approach that addresses clinical needs in diagnosis, treatment and prevention using both experimental and computational methods. Translational Medicine awards will advance training and support career development of early-career scientists engaged in research that significantly addresses specific clinician-defined problems and integrates innovative technologies with advanced biological, chemical, and pharmacological sciences and engineering methodologies.
The application portal for this year’s PhRMA Foundation Translational Medicine awards is now open and applications are due today, February 10, 2022 at 11:59 PM EST. Recipients of awards will be notified no later than April 15, 2022. Postdoctoral fellowships are provided for two years and offer $60,000 in stipend support per year. Research starter grants are provided for one year and offer funding of $100,000.
Career Center
The ACTS Career Center is the premier resource for connecting those in the field of translational science with career opportunities. Visit today to find a wealth of resources to help achieve your career goals.
ACTS members receive a 50% discount on the site—use code ACTSMEMBER to save!
Member Highlights
Do you know someone who deserves to be recognized for outstanding or groundbreaking work? Is your institution embarking on an exciting project? Send ACTS your story to be highlighted in future versions of ACTS Connection.
Submit stories here.
Translational Science Today
Kraschnewski named director of Clinical Translational...
Dr. Jennifer Kraschnewski has assumed the role of director of Penn State Clinical and Translational Science Institute effective Feb. 7.
Read more
www.psu.edu